The convergence of rising autonomous vehicle development and the growing trend toward connected cars fuel a significant demand for automotive AI chipsets. This report, A Comprehensive Analysis of the Automotive AI Chipset Ecosystem, 2034, presents a comprehensive view of this dynamic market, highlighting lucrative opportunities for industry stakeholders. NEWARK, Del., Dec. 7, 2023 /PRNewswire/ —… Continue reading The passenger Vehicle Segment is expected to constitute a share of 72.0% in the Automotive AI Chipset Market in 2024 | Future Market Insights, Inc.
Tag: Strategy
NWTN Announces Strategic Partnership with China State Construction Engineering Corporation (Middle East)
DUBAi, UAE, Dec. 7, 2023 /PRNewswire/ — NWTN Inc. (Nasdaq: NWTN), an eco-conscious mobility technology company bringing passenger-centric green premium mobility solutions to the world (“NWTN” or the “Company”), is thrilled to announce a landmark Memorandum of Understanding (MOU) with China State Construction Engineering Corporation (Middle East) LLC (CSCEC), marking a significant stride in international cooperation… Continue reading NWTN Announces Strategic Partnership with China State Construction Engineering Corporation (Middle East)
Maine Condo Project to Offer Turnkey Restoration Hardware Units
Developer Mark McClure expects RH Collaboration to elevate condo owners rental profits PORTLAND, Maine, Dec. 10, 2023 /PRNewswire/ — The Mark at Cumberland Foreside, an upscale, 45-unit condo development, has reached 40% of construction completed. The project, spearheaded by developer Mark McClure, has garnered widespread, regional attention, sparking inquiries from prospective buyers spanning across New England,… Continue reading Maine Condo Project to Offer Turnkey Restoration Hardware Units
The Cigna Group Announces Significant Increase to Share Repurchase Program of $10 Billion
Intends to Repurchase at Least $5 Billion of Common Stock by End of First Half of 2024, with Portion Executed Via ASR in First Quarter 2024 Reaffirms Previously Provided Outlook for Full-Year 2023 BLOOMFIELD, Conn., Dec. 10, 2023 /PRNewswire/ — Global health company The Cigna Group (NYSE: CI) today announced that its Board of Directors has… Continue reading The Cigna Group Announces Significant Increase to Share Repurchase Program of $10 Billion
Sanofi and Minapharm Sign an Exclusive Agreement for Localizing the manufacture of Clexane®
CAIRO and PARIS, Dec. 10, 2023 /PRNewswire/ — Sanofi and Minapharm announce the signing of an exclusive Manufacturing and Supply Agreement for the localization of the full range of its flagship market leader product, Clexane®. Continue Reading Sanofi and Minapharm Sign an Exclusive Agreement for Localizing the manufacture of Clexane® (PRNewsfoto/Minapharm Pharmaceuticals) The agreement between… Continue reading Sanofi and Minapharm Sign an Exclusive Agreement for Localizing the manufacture of Clexane®
The federal government must urgently solve the budget crisis – uncertainty endangers democracy and jobs
Berlin/Hannover/Frankfurt am Main – In view of the still unresolved budget crisis, DGB, IG Metall and IGBCE are warning of an exodus from industry and the loss of thousands of jobs. They call on federal and state politicians to quickly develop viable solutions to the challenges posed by the Federal Constitutional Court’s ruling. In the… Continue reading The federal government must urgently solve the budget crisis – uncertainty endangers democracy and jobs
DERMTECH ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In DermTech To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $25,000 investing in DermTech stock or options between March 8, 2021 and November 3, 2022 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/DMTK. There is no cost or… Continue reading DERMTECH ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In DermTech To Contact Him Directly To Discuss Their Options
LI-CYCLE ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Li-Cycle To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $50,000 investing in Li-Cycle securities between June 14, 2022 and October 23, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/LICY. There is no cost or obligation to… Continue reading LI-CYCLE ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Li-Cycle To Contact Him Directly To Discuss Their Options
SCYNEXIS ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Scynexis To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $25,000 investing in Scynexis securities between March 31, 2023 and September 22, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/SCYX. There is no cost or obligation to… Continue reading SCYNEXIS ONGOING DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Scynexis To Contact Him Directly To Discuss Their Options
BRAINSTORM DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Brainstorm To Contact Him Directly To Discuss Their Options
If you suffered losses exceeding $25,000 investing in Brainstorm securities between August 15, 2022 and September 27, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/BCLI. There is no cost or obligation to… Continue reading BRAINSTORM DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Brainstorm To Contact Him Directly To Discuss Their Options